Vanguard Group Inc Night Hawk Biosciences, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.15 - $0.45 $16,956 - $50,868	-113,041 Reduced 23.71%	363,719 $58,000
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.51 $161,517 - $316,822	-621,220 Reduced 56.58%	476,760 $209,000
Q4 2022 Feb 10, 2023	BUY	$0.77 - $1.62 $501 - $1,054	651 Added 0.06%	1,097,980 $889,000
Q1 2022 May 13, 2022	SELL	$2.1 - $3.54 $46,907 - $79,072	-22,337 Reduced 1.99%	1,097,329 $3.36 Million
Q4 2021 Feb 14, 2022	SELL	$3.04 - $6.01 $4,721 - $9,333	-1,553 Reduced 0.14%	1,119,666 $3.4 Million
Q2 2021 Aug 13, 2021	BUY	$5.78 - $9.6 $6.48 Million - $10.8 Million	1,121,219 New	1,121,219 $7.55 Million

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.